Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
19.66
-0.63 (-3.10%)
At close: May 14, 2025, 4:00 PM
19.40
-0.26 (-1.32%)
After-hours: May 14, 2025, 4:58 PM EDT
Fulgent Genetics Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Fulgent Genetics stock ranges from a low of $23 to a high of $25. The average analyst price target of $24 forecasts a 22.08% increase in the stock price over the next year.
Price Target: $24.00 (+22.08%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Fulgent Genetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $16 → $23 | Hold | Maintains | $16 → $23 | +16.99% | May 6, 2025 |
| Raymond James | Raymond James | Buy Reiterates $24 → $25 | Buy | Reiterates | $24 → $25 | +27.16% | May 5, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $22 → $16 | Hold | Maintains | $22 → $16 | -18.62% | Mar 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $26 → $22 | Hold | Maintains | $26 → $22 | +11.90% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $28 → $25 | Hold | Maintains | $28 → $25 | +27.16% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
316.90M
from 283.47M
Increased by 11.79%
Revenue Next Year
350.01M
from 316.90M
Increased by 10.45%
EPS This Year
-0.67
from -1.41
EPS Next Year
-0.62
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 327.9M | 363.1M | 397.6M |
| Avg | 316.9M | 350.0M | 383.4M |
| Low | 302.6M | 333.3M | 367.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 15.7% | 14.6% | 13.6% |
| Avg | 11.8% | 10.4% | 9.5% |
| Low | 6.8% | 5.2% | 4.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.67 | -0.63 | -0.58 |
| Avg | -0.67 | -0.62 | -0.56 |
| Low | -0.67 | -0.61 | -0.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.